Ferroptosis inhibitors have been shown to reduce amyloid-beta (Aβ) aggregation-induced neuronal death and memory impairment, while restoring Fpn expression ameliorates ferroptosis and improves cognitive function in AD mice (Bao et al., 2021). The gene discussed is SLC40A1; the disease is Alzheimer disease.